Diclofenac

Generic Name
Diclofenac
Brand Names
Aleve Arthritis Pain, Arthrotec, Cambia, Cataflam, Flector, Licart, Lofena, Pennsaid, Previdolrx Analgesic Pak, Salonpas Pain Relieving Patch, Solaraze, Voltaren, Voltaren Emulgel, Xrylix, Zipsor, Zorvolex
Drug Type
Small Molecule
Chemical Formula
C14H11Cl2NO2
CAS Number
15307-86-5
Unique Ingredient Identifier
144O8QL0L1
Background

Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID). NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and in...

Indication

Diclofenac is indicated for use in the treatment of pain and inflammation from varying sources including inflammatory conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, as well as injury-related inflammation due to surgery and physical trauma. It is often used in combination with misoprostol as a gastro-protective agent in p...

Associated Conditions
Actinic Keratosis (AK), Acute Arthritis, Acute Gouty Arthritis, Acute Migraine, Acute Musculoskeletal Pain, Ankylosing Spondylitis (AS), Common Cold, Fever, Gout, Inflammation, Inflammatory Disease of the Oral Cavity, Inflammatory Disease of the throat, Inflammatory Reaction of the Nerve, Joint Pain, Juvenile Idiopathic Arthritis (JIA), Menstrual Distress (Dysmenorrhea), Muscle Inflammation, Myalgia, Neuropathic Pain, Ocular Inflammation, Osteoarthritis (OA), Osteoarthritis of the Knee, Pain, Pain caused by Rheumatism, Pericarditis, Photophobia, Postoperative Inflammatory Response, Postoperative pain, Primary Dysmenorrhoea, Radicular Pain, Rheumatism, Rheumatoid Arthritis, Seasonal Allergic Conjunctivitis, Spinal pain, Tendon pain, Vertebral column pain, Acute Musculoskeletal injury, Acute, moderate, severe Pain, Inflammatory, Localized soft tissue rheumatism, Mild to moderate joint pain, Mild to moderate pain, Minor pain, Perioperative miosis
Associated Therapies
-

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Phase 3
Completed
Conditions
Interventions
First Posted Date
2015-11-23
Last Posted Date
2017-05-05
Lead Sponsor
Teva Pharmaceuticals USA
Target Recruit Count
492
Registration Number
NCT02611804
Locations
🇺🇸

Tampa Bay Medical Research, Clearwater, Florida, United States

🇺🇸

Greenville Dermatology, Greenville, South Carolina, United States

🇺🇸

Clinical Science Institute, Santa Monica, California, United States

and more 26 locations

Efficacy of Preprocedural Diclofenac in Males Undergoing Double J Stent Removal Under Local Anesthesia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2015-11-05
Last Posted Date
2018-08-28
Lead Sponsor
Institute of Nephro Urology, Bangalore
Target Recruit Count
150
Registration Number
NCT02598102
Locations
🇮🇳

Institute of Nephro Urology, Bangalore, Karnataka, India

Effectiveness of Diclofenac and Its Association to Codeine After Lower Third Molar Extraction.

First Posted Date
2015-09-11
Last Posted Date
2015-09-11
Lead Sponsor
University of Sao Paulo
Target Recruit Count
50
Registration Number
NCT02547896

Safety and Efficacy of Neuromultivit in Treatment of Vertebrogenic Radiculopathy

First Posted Date
2015-07-27
Last Posted Date
2017-05-09
Lead Sponsor
Bausch Health Americas, Inc.
Target Recruit Count
100
Registration Number
NCT02508805
Locations
🇷🇺

State Autonomous Institution Republican Clinical Centre of Neurology, Kazan, Republic of Tatarstan, Russian Federation

Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort

First Posted Date
2015-07-23
Last Posted Date
2015-07-24
Lead Sponsor
Wolfson Medical Center
Target Recruit Count
30
Registration Number
NCT02506348
Locations
🇮🇱

The E.Wolfson Medical Center, Holon, Israel

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

First Posted Date
2015-07-13
Last Posted Date
2016-04-15
Lead Sponsor
Zambon SpA
Target Recruit Count
24
Registration Number
NCT02495831
Locations
🇨🇭

Cross Research SA, Phase I Unit, Arzo, Ticino, Switzerland

A Study to Assess the Efficacy and Tolerability of Diclofenac Potassium Soft Gelatin Capsules Compared With Ibuprofen Tablets in Patients With Moderate to Severe Postoperative Dental Pain

First Posted Date
2015-06-19
Last Posted Date
2016-10-17
Lead Sponsor
Novartis Pharmaceuticals
Target Recruit Count
328
Registration Number
NCT02476422
Locations
🇺🇸

Novartis Investigative Site, Austin, Texas, United States

Diclofenac Premedication, as the Effect of Preemptive Analgesia After Post-thoracotomy Chest and Shoulder Pain

First Posted Date
2015-05-15
Last Posted Date
2017-03-09
Lead Sponsor
University of Debrecen
Target Recruit Count
3
Registration Number
NCT02445599
Locations
🇭🇺

UNIVERSITY OF DEBRECEN FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care, Debrecen, Hajdú-Bihar, Hungary

© Copyright 2024. All Rights Reserved by MedPath